Novolin Ge 30/70 30 Unit

NOVOLIN GE 30/70 30 Unit is a human biosynthetic insulin suspension designed for subcutaneous administration. It combines rapid-acting and intermediate-acting insulin to manage blood glucose levels. Ideal for diabetes management, this 10mL suspension offers a balanced approach to insulin therapy.

NOVOLIN GE 30/70 30 Unit is primarily used for the management of diabetes mellitus. This insulin suspension helps regulate blood sugar levels by providing both immediate and prolonged insulin effects. It is often prescribed for individuals who require a combination of rapid-acting and intermediate-acting insulin to maintain stable glucose control throughout the day.

When administered subcutaneously, NOVOLIN GE 30/70 30 Unit works to lower blood sugar levels. Users may experience effects such as reduced hunger and improved energy levels as blood glucose is managed. It is important to monitor blood sugar levels regularly to assess the effectiveness of the treatment.

NOVOLIN GE 30/70 30 Unit should be stored properly to maintain its efficacy. It is crucial to follow the storage instructions provided to ensure the insulin remains effective. Always check the suspension for any changes in appearance before use. Consult a healthcare provider for personalized advice on handling and storage.

NOVOLIN GE 30/70 30 Unit may interact with other medications, including oral hypoglycemic agents and certain antibiotics. Alcohol consumption can also affect blood sugar levels and should be monitored closely. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.